Aftercare for Prostate Cancer Survivors
Study name: Increasing the Dose of Survivorship Care Planning in Prostate Cancer Survivors Who Receive Androgen Deprivation Therapy
Description: Researchers at the WL Nugent Cancer Center are conducting a Phase II clinical trial to determine how survivorship care planning can best improve follow-up care and outcomes for patients with prostate cancer after they have completed cancer treatment.
- Group 1 (standard care planning): Survivorship care planning occurs after patient completes treatment with radiation therapy.
- Group 2 (enhanced care planning): Survivorship care planning occurs prior to radiation therapy and then again after patient completes radiation therapy.
Who can participate?
This study is open to men age 18 and over who:
- Have been diagnosed with prostate cancer
- Will receive radiation therapy and hormone therapy known as Androgen Deprivation Therapy to treat their cancer
- Have a primary care provider or cardiologist for involvement in their follow-up care.
What to expect
-
You will meet with your doctor to discuss what is involved in the study and the possible benefits and risks. If you and your doctor agree this clinical trial is right for you, you will be asked to sign a consent form.
-
This is a randomized study, where you will be assigned by chance to one of the groups listed above.
-
You will periodically complete questionnaires about the quality of your medical care and compliance with your Survivorship Care Plan.
Please talk with your doctor about whether this clinical trial is right for you.